Ask AI

Mastering Systemic Mastocytosis: Diagnostic Criteria, Risk Stratification, and Patient-Centered Treatment Across Indolent and Advanced Disease

Improve your ability to apply current diagnostic recommendations, differentiate indolent and advanced disease, and select evidence-based therapies for patients with systemic mastocytosis while incorporating risk stratification, patient needs and preferences, and multidisciplinary management strategies through an expert-written ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Events

Activities

SM: Diagnosis, Risk, and Personalized Care
ClinicalThought Expert Office Hours Forum: Mastering Systemic Mastocytosis: Diagnostic Criteria, Risk Stratification, and Patient-Centered Treatment Across Indolent and Advanced Disease
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 06, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by an educational grant from Blueprint Medicines, a Sanofi company.

Blueprint Medicines, a Sanofi company